← SynDRA
FIBOFLAPON
SynDRA canonical compound SYN0028423 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ALOX5AP |
|---|
| Mechanism of action | lipoxygenase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ALOX5AP INHIBITOR
- 5-lipoxygenase activating protein inhibitor
- lipoxygenase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX5
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- HDAC6
- LTA4H
- LTC4S
- PTGS1
- PTGS2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- GAMT
- GNMT
- HNMT
- NNMT
- PNMT
Cross-references
Synonyms
- AM803
- AM-803
- CHEMBL1922660
- GSK-2190915
- GSK2190915
- GSK2190915B
- sirtuin modulator
- SRT-2104
- SRT2104 (GSK2245840)
- SRT2104
- UNII-4521NR0J09
- 4521NR0J09
- 5-Thiazolecarboxamide, 4-methyl-N-[2-[3-(4-morpholinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-(3-pyridinyl)-
- C26H24N6O2S2
- 4-Methyl-N-(2-{3-[(morpholin-4-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)-2-(pyridin-3-yl)-1,3-thiazole-5-carboxamide
- 4-methyl-n-(2-(3-(morpholinomethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-(pyridin-3-yl)thiazole-5-carboxamide
- AM 803
- Fiboflapon [USAN:INN]
- UNII-Y1NA96IX3T
- Y1NA96IX3T
- Fiboflapon (USAN)
- FIBOFLAPON [INN]
- FIBOFLAPON [USAN]
- FIBOFLAPON [WHO-DD]
- fiboflaponum
- RefChem:140378
- DTXCID40161987
- GSK2190915;AM-803
- AM-803;Fiboflapon
- SCHEMBL11820
- orb1709537
- SCHEMBL29379276
- SCHEMBL29723363
- C38H43N3O4S
- CHEBI:177852
- DFQGDHBGRSTTHX-UHFFFAOYSA-N
- GLXC-21004
- BDBM50359080
- AKOS030527019
Look up FIBOFLAPON in the interactive SynDRA portal →